Delivery Order SPE2DB25D3404-SPE2DB25FUQLL
- Not listed
- The Defense Logistics Agency awarded a $62,114.93 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of May 20, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office...
- The Defense Logistics Agency awarded a $13,844.92 delivery order to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This non-set-aside, competitively awarded contract utilized firm fixed pricing and was completed on July 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of the company's established role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $26,090.03 for ENBREL 50 mg/ml SureClick auto-injectors, with an ultimate completion date of April 25, 2025. This firm fixed price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. The pharmaceutical will be...
- The Defense Logistics Agency awarded a $10,451.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors on July 11, 2025, with performance completion scheduled for July 14, 2025. This non-competitive delivery order, issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, represents a continuation of the company's critical role as a pharmaceutical supplier to federal military and...
- The Defense Logistics Agency awarded a delivery order valued at $31,940.40 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract supports the federal government's pharmaceutical procurement needs through AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,351.37 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of ENBREL 50 mg/ml SureClick auto-injectors. The contract is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a $11,741.33 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors on June 18, 2025, with an ultimate completion date of June 20, 2025. This non-competitive, firm fixed-price delivery order was issued under a child contract structure, leveraging AmerisourceBergen's established relationship with the federal government's medical supply chain. The contract was performed at the company's corporate office location in...
- The Defense Logistics Agency awarded a $31,964.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of September 5, 2025. This non-competitive delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement valued through December 2026. The product being delivered—ENBREL, a...
- The Defense Logistics Agency awarded a $13,880.31 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors, with an ultimate completion date of September 15, 2025. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply agreement running through December 2026. The product will be performed at the...
- The Defense Logistics Agency awarded a delivery order valued at $15,705.82 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of September 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUQLLDelivery Order
The Defense Logistics Agency awarded a $8,708.90 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of September 17, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The pharmaceutical product will be sourced from the vendor's Conshohocken, Pennsylvania facility, where AmerisourceBergen operates as a major distributor of medical supplies and medications to federal healthcare systems. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of medications, vaccines, and medical supplies to military healthcare programs and other federal customers, including the Defense Health Agency and U.S. Coast Guard. ENBREL, a specialty medication used for treating autoimmune conditions, exemplifies the types of critical therapeutic agents that AmerisourceBergen delivers through its DLA contracts to support military medical readiness and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 9/16/25 |